1511
263
111
74
68
68
64
57
53
49
49
44
44
43
40
36
35
32
31
31
29
27
25
24
23
22
20
19
19
19
17
17
17
16
16
15
15
14
13
13
12
12
12
12
11
11
11
11
11
10
9
8
8
8
7
7
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11609
1160
2749
274
3179
317
J CLIN ONCOL
RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine
PDF的下载单位、IP信息已删除
(2025-6-4)